Shares of Annovis Bio, Inc. (ANVS) have gained 0.9% over the past four weeks to close the last trading session at 11.88,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof35.40 indicates a potential upside of 198%.The mean estimate comprises five short-term price targets with a standard deviation of 22.13.Whilethelowestestimateof13 indicates a 9.4% increase from the curr ...